Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris
- Conditions
- Acne Vulgaris
- Registration Number
- NCT02905851
- Lead Sponsor
- University of California, Davis
- Brief Summary
To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris
- Detailed Description
The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use.
There are two arms of the study:
1. Feedback group
2. Non feedback group
All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months).
The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
- Subjects aged 15 years and older
- Subjects who have been prescribed doxycycline or minocycline by their physician for acne vulgaris but have not initiated treatment yet.
- Subjects who have used isotretinoin in the last 6 weeks
- Those who have used oral antibiotics within the last 4 weeks
- Those who have been initiated or changed brand of oral contraceptive pill within the last one month.
- Those subjects who cannot engage with the teledermatology platform
- Prisoners
- Adults unable to consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Reduced antibiotic use Assessed at 4, 8, 12 weeks The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UC Davis Department of Dermatology, Clinical Trials Unit
🇺🇸Sacramento, California, United States
UC Davis Department of Dermatology, Clinical Trials Unit🇺🇸Sacramento, California, United States